Harmony Biosciences Investor Day
Oct 1, 2024 8:30 AM EDT
Supporting Materials
Agenda
SLEEP/WAKE FRANCHISE
- Jeffrey Dierks, MBA - CCO
- Wakix
- Pitolisant-HD
- Kumar Budur, MD, MS – CMO, CSO
- Pitolisant-HD
- IH
- BP1.15205 (OX2R)
- Bruce Corser, MD (KOL) & Kumar Budur, MD
- Sleep/Wake – Fireside Chat
NEUROBEHAVIORAL FRANCHISE
- CARRIE BUCHANAN, MD (KOL)
- Fragile X Syndrome (FXS)
- ZYN002 – CONNECT Trial
- Kumar Budur, MD, MS – CMO, CSO
- ZYN002 – RECONNECT Trial
EPILEPSY FRANCHISE
- Kumar Budur, MD, MS – CMO, CSO
- EPX-100 (Clemizole HCl)
- SCOTT C. BARABAN, PhD (KOL)
- Zebrafish / Predictive model
- EPX-100 (Clemizole HCl)
MANAGEMENT PANEL DISCUSSION
- Q&A